C9orf57

gene
On this page

Summary

C9orf57 (chromosome 9 open reading frame 57, HGNC:27037) is a protein-coding gene on chromosome 9q21.13, encoding Uncharacterized protein C9orf57 (Q5W0N0).

Predicted to be located in membrane.

Source: NCBI Gene 138240 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 3 total — 1 pathogenic
  • MANE Select transcript: NM_001128618

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:27037
Approved symbolC9orf57
Namechromosome 9 open reading frame 57
Location9q21.13
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000204669
Ensembl biotypeprotein_coding
Entrez138240

Gene structure

Transcript identifiers

Ensembl transcripts: 7 — 5 protein_coding, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined

ENST00000377024, ENST00000424431, ENST00000651121, ENST00000651200, ENST00000652156, ENST00000652752, ENST00000673779

RefSeq mRNA: 2 — MANE Select: NM_001128618 NM_001128618, NM_001371610

CCDS: CCDS47980

Canonical transcript exons

ENST00000651200 — 5 exons

ExonStartEnd
ENSE000014725237205607472056196
ENSE000014725277205678472056843
ENSE000018769087205137672052435
ENSE000038430567205923572059384
ENSE000038488777206049772060613

Expression profiles

Bgee: expression breadth broad, 13 present calls, max score 84.40.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0509 / max 41.0487, expressed in 3 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
1009370.01893
1009380.01653
1009390.01553

Top tissues by expression

231 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047384.40gold quality
right testisUBERON:000453479.12gold quality
left testisUBERON:000453378.27gold quality
testisUBERON:000047376.89gold quality
adult organismUBERON:000702376.05gold quality
ileal mucosaUBERON:000033158.75silver quality
pancreatic ductal cellCL:000207955.40silver quality
cardiac muscle of right atriumUBERON:000337954.34gold quality
left ventricle myocardiumUBERON:000656654.23gold quality
kidney epitheliumUBERON:000481953.93gold quality
upper arm skinUBERON:000426353.52gold quality
deltoidUBERON:000147652.36gold quality
myocardiumUBERON:000234950.25gold quality
quadriceps femorisUBERON:000137747.18gold quality
nasal cavity epitheliumUBERON:000538447.03gold quality
vastus lateralisUBERON:000137945.40gold quality
skin of hipUBERON:000155443.68silver quality
layer of synovial tissueUBERON:000761643.55gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451143.37gold quality
skeletal muscle tissueUBERON:000113442.72gold quality
secondary oocyteCL:000065542.57gold quality
muscle tissueUBERON:000238542.52gold quality
spermCL:000001941.55gold quality
superficial temporal arteryUBERON:000161441.33gold quality
palpebral conjunctivaUBERON:000181241.10gold quality
mucosa of paranasal sinusUBERON:000503040.98gold quality
cartilage tissueUBERON:000241840.77gold quality
amniotic fluidUBERON:000017340.69gold quality
jejunal mucosaUBERON:000039940.59gold quality
biceps brachiiUBERON:000150740.57gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes3.45

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

51 targeting C9orf57, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4476100.0068.182030
HSA-MIR-6876-5P100.0067.682126
HSA-MIR-12118100.0065.881270
HSA-MIR-4795-3P100.0074.624024
HSA-MIR-3646100.0073.565283
HSA-MIR-6870-5P99.9968.552115
HSA-MIR-3173-3P99.9866.491217
HSA-MIR-6891-5P99.9866.531372
HSA-MIR-4723-5P99.9768.702034
HSA-MIR-569899.9768.492029
HSA-MIR-7111-5P99.9768.482062
HSA-MIR-590-3P99.9674.346478
HSA-MIR-570-3P99.9672.414910
HSA-MIR-205-3P99.9269.923165
HSA-MIR-7162-3P99.8968.161682
HSA-MIR-391999.8769.452489
HSA-MIR-444799.8567.812900
HSA-MIR-4659A-3P99.8072.624248
HSA-MIR-4659B-3P99.8072.624248
HSA-MIR-4446-5P99.7269.192544
HSA-MIR-430699.7270.503630
HSA-MIR-494-3P99.7071.452795
HSA-MIR-509399.6769.262291
HSA-MIR-182799.6368.573265
HSA-MIR-7152-5P99.6069.332094
HSA-MIR-426199.5970.303415
HSA-MIR-3942-3P99.5769.032854
HSA-MIR-432899.5771.064094
HSA-MIR-4649-3P99.5666.901783
HSA-MIR-185-5P99.3568.602497

Cross-species orthologs

0 orthologs

Protein

Protein identifiers

Uncharacterized protein C9orf57Q5W0N0 (reviewed: Q5W0N0)

All UniProt accessions (4): Q5W0N0, A0A494C027, A0A494C0F4, A0A494C1R2

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Membrane.

Isoforms (2)

UniProt IDNamesCanonical?
Q5W0N0-11yes
Q5W0N0-22

RefSeq proteins (2): NP_001122090, NP_001358539 (=MANE)

Domains & families (InterPro)

IDNameType
IPR031710DUF4723Family

Pfam: PF15851

UniProt features (3 total): chain 1, transmembrane region 1, splice variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q5W0N0-F169.040.20

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 20 (showing top): chr9q21, ZNF274_TARGET_GENES, MIR4328, MIR4306, MIR1827, MIR3942_3P, MIR4446_5P, MIR6868_3P, MIR4723_5P, MIR6870_5P, MIR7111_5P, MIR5698, MIR6876_5P, MIR4476, MIR4649_3P

GO Biological Process (0):

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (1): membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
binding1
cellular anatomical structure1

Protein interactions and networks

STRING

42 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
C9orf57C9orf85Q96MD7716
C9orf57ABHD17BQ5VST6577
C9orf57ZFAND5O76080507
C9orf57CEMIP2Q9UHN6448
C9orf57TRPM3Q9HCF6336
C9orf57TMC2Q8TDI7287
C9orf57TJP2Q9UDY2272
C9orf57GJB2P29033271
C9orf57TMC8Q8IU68264
C9orf57ANXA1P04083222
C9orf57SLC25A15Q9Y619213
C9orf57MYO15AQ9UKN7203
C9orf57ALDH1A1P00352202
C9orf57OTOFQ9HC10192
C9orf57CDH23Q9H251160

IntAct

1 interactions, top by confidence:

BioGRID (3): C9orf57 (Two-hybrid), GPSM3 (Two-hybrid), C9orf57 (Positive Genetic)

ESM2 similar proteins: A0A0J9YY54, A4K2M6, A4K2P0, A4K2P8, A4K2T3, A4K2U1, A4K2Y4, A6NF34, A6NI47, B3A0S1, D1FNK2, D3YZV8, D9IX97, O43493, P16225, P19957, P26436, P62521, Q06990, Q0P6D6, Q27J49, Q28139, Q29125, Q29126, Q4R729, Q4ZJY8, Q5F378, Q5JRC9, Q5QGU6, Q5SRN2, Q5W0N0, Q63HK3, Q6H9L7, Q6IC83, Q6S545, Q7M3V1, Q8BVC1, Q8CHN3, Q8N2N9, Q8N660

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

3 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic0
Uncertain significance2
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
59107GRCh38/hg38 9q21.13(chr9:72023067-72497412)x1Pathogenic

SpliceAI

465 predictions. Top by Δscore:

VariantEffectΔscore
9:72056844:C:CCacceptor_gain0.9900
9:72060496:CCTAT:Cdonor_gain0.9900
9:72060500:T:Cdonor_gain0.9900
9:72056200:CAAG:Cacceptor_gain0.9700
9:72056203:G:GCacceptor_gain0.9700
9:72056213:A:Tacceptor_gain0.9700
9:72056856:CA:Cacceptor_gain0.9700
9:72056203:G:Cacceptor_gain0.9600
9:72056206:C:CTacceptor_gain0.9600
9:72056212:C:CTacceptor_gain0.9600
9:72056855:CCA:Cacceptor_gain0.9600
9:72060492:CCTA:Cdonor_loss0.9600
9:72060493:CTAC:Cdonor_loss0.9600
9:72060494:TAC:Tdonor_loss0.9600
9:72060495:ACC:Adonor_loss0.9600
9:72056844:CTAAA:Cacceptor_loss0.9500
9:72056845:T:Aacceptor_loss0.9500
9:72056857:A:Cacceptor_gain0.9400
9:72059322:T:TAdonor_gain0.9400
9:72052434:ACC:Aacceptor_loss0.9300
9:72052435:CCT:Cacceptor_loss0.9300
9:72052436:C:Aacceptor_loss0.9300
9:72052437:T:Aacceptor_loss0.9300
9:72056199:CCAAG:Cacceptor_gain0.9300
9:72056207:A:Tacceptor_gain0.9300
9:72056839:CAGGT:Cacceptor_gain0.9300
9:72056853:A:Tacceptor_loss0.9300
9:72056237:A:Cacceptor_gain0.9200
9:72060490:GACCT:Gdonor_loss0.9200
9:72060491:ACCTA:Adonor_loss0.9200

AlphaMissense

893 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
9:72052422:C:AW120C0.972
9:72052422:C:GW120C0.972
9:72056150:G:CF90L0.961
9:72056150:G:TF90L0.961
9:72056152:A:GF90L0.961
9:72052424:A:GW120R0.954
9:72052424:A:TW120R0.954
9:72056169:C:TC84Y0.930
9:72052405:C:GC126S0.929
9:72052406:A:TC126S0.929
9:72052380:G:CF134L0.925
9:72052380:G:TF134L0.925
9:72052382:A:GF134L0.925
9:72056178:C:GC81S0.919
9:72056179:A:TC81S0.919
9:72052384:C:GC133S0.917
9:72052385:A:TC133S0.917
9:72056179:A:GC81R0.917
9:72056177:G:CC81W0.916
9:72056178:C:TC81Y0.915
9:72056169:C:GC84S0.913
9:72056170:A:TC84S0.913
9:72056142:C:GC93S0.902
9:72056143:A:TC93S0.902
9:72052306:C:GC159S0.901
9:72052307:A:TC159S0.901
9:72052385:A:GC133R0.900
9:72056143:A:GC93R0.900
9:72056168:G:CC84W0.892
9:72052299:G:CF161L0.891

dbSNP variants (sampled 300 via entrez): RS1000108941 (9:72053397 A>G,T), RS1000292371 (9:72053703 C>T), RS1000555407 (9:72057868 A>G), RS1000652553 (9:72059482 T>C), RS1000897764 (9:72052071 A>G), RS1001003468 (9:72058177 T>A,C,G), RS1001201867 (9:72059572 A>G), RS1001221018 (9:72060872 T>C), RS1001320815 (9:72053504 C>T), RS1001437585 (9:72061640 C>A), RS1001517266 (9:72051708 A>G), RS1001563833 (9:72055129 G>A), RS1002422790 (9:72058420 C>G), RS1002891436 (9:72062245 T>C), RS1002994466 (9:72055135 C>T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

7 total (human), top 7 by PubMed support.

ChemicalActions (top 5)PubMed papers
propionaldehydedecreases methylation1
nonanaldecreases methylation1
n-hexanaldecreases methylation1
butyraldehydedecreases methylation1
caprylic aldehydedecreases methylation1
pentanaldecreases methylation1
heptanaldecreases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.